Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hakan Harputluoglu

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Gastrointestinal Cancer|February 4, 2022
Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory MarkersAhmet Gulmez, Hakan Harputluoglu
Medical Hypotheses|July 18, 2006
Statins may decrease skeletal-related events in breast cancer patients with bone metastasesMurat Dincer, Nilufer Bulut, Hakan Harputluoglu, et al.
Cancer Treatment and Research Communications|April 3, 2021
Acute sunitinib neurotoxicityAhmet Gulmez, Mustafa Dikilitas, Emin Tamer Elkiran, et al.
Medical Hypotheses|June 20, 2006
Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancerSercan Aksoy, Hatice Aksoy, Hakan Harputluoglu, et al.
European Journal of Haematology|January 29, 2008
Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis COmer Dizdar, Umit Tapan, Sercan Aksoy, et al.
Medical Oncology (Northwood, London, England)|January 16, 2008
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastasesMurat Dincer, Kadri Altundag, Hakan Harputluoglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2010
Zoledronic acid and atrial fibrillation in cancer patientsCagatay Arslan, Sercan Aksoy, Omer Dizdar, et al.
Journal of Cancer Research and Therapeutics|June 7, 2019
Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?Asude Aksoy, Emin Tamer Elkiran, Hakan Harputluoglu, et al.
Leukemia & Lymphoma|July 7, 2007
Rituximab-related viral infections in lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgiaOmer Dizdar, Levent Ozçakar, Fevziye Unsal Malas, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Gastrointestinal Cancer|February 4, 2022
Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory MarkersAhmet Gulmez, Hakan Harputluoglu
Medical Hypotheses|July 18, 2006
Statins may decrease skeletal-related events in breast cancer patients with bone metastasesMurat Dincer, Nilufer Bulut, Hakan Harputluoglu, et al.
Cancer Treatment and Research Communications|April 3, 2021
Acute sunitinib neurotoxicityAhmet Gulmez, Mustafa Dikilitas, Emin Tamer Elkiran, et al.
Medical Hypotheses|June 20, 2006
Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancerSercan Aksoy, Hatice Aksoy, Hakan Harputluoglu, et al.
European Journal of Haematology|January 29, 2008
Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis COmer Dizdar, Umit Tapan, Sercan Aksoy, et al.
Medical Oncology (Northwood, London, England)|January 16, 2008
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastasesMurat Dincer, Kadri Altundag, Hakan Harputluoglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2010
Zoledronic acid and atrial fibrillation in cancer patientsCagatay Arslan, Sercan Aksoy, Omer Dizdar, et al.
Journal of Cancer Research and Therapeutics|June 7, 2019
Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?Asude Aksoy, Emin Tamer Elkiran, Hakan Harputluoglu, et al.
Leukemia & Lymphoma|July 7, 2007
Rituximab-related viral infections in lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgiaOmer Dizdar, Levent Ozçakar, Fevziye Unsal Malas, et al.
Pageof 4